Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-03T08:11:07.654Z Has data issue: false hasContentIssue false
  • English
  • Français

SOCIOECONOMIC COSTS OF RHEUMATIC DISEASES

Implications for Technology Assessment

Published online by Cambridge University Press:  25 May 2001

Dick Jonsson  and
Magnus Husberg
Dick Jonsson
Affiliation:
Linköping University
Magnus Husberg
Affiliation:
Linköping University
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives: To study the socioeconomic impact of rheumatic illness in Sweden and to discuss the consequences for technology assessment studies.

Methods: A cost-of-illness study based on data from official statistics and treatment studies.

Results: The total socioeconomic cost was 52 billion Swedish kronor (SEK) in 1994. The imbalance between direct (10% of total) and indirect costs (90effectiveness of the healthcare sector, the need for new treatment methods, appropriate information systems, and technology assessment studies as well as the institutional arrangements for rehabilitation and basic medical research.

Conclusions: A discussion of solutions for financial cooperation between county councils and regional social insurance offices should be considered. The new biotechnological pharmaceuticals will increase the cost for drugs in health care about 20 times, but the total socioeconomic cost for society may remain at the same level due to a decrease of inpatient costs and indirect costs for loss of production as well as a decrease of transfer payments from social insurance. It is unavoidable that the new pharmaceuticals require priority discussions and active resource allocation in health care and in other sectors of society.

Keywords

Rheumatic diseasesSocioeconomicCost of illnessQuality of lifeRehabilitation
Type
Research Article
Information
International Journal of Technology Assessment in Health Care , Volume 16 , Issue 04 , October 2000 , pp. 1193 - 1200
Copyright
© 2000 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)